These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6171518)

  • 21. Noncorrelation between mouse toxicity and serologically assayed toxin in Clostridium botulinum type A culture fluids.
    Betley MJ; Sugiyama H
    Appl Environ Microbiol; 1979 Aug; 38(2):297-300. PubMed ID: 391153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Clostridium botulinum type E toxin purified by two different procedures.
    Yokosawa N; Tsuzuki K; Syuto B; Oguma K
    J Gen Microbiol; 1986 Jul; 132(7):1981-8. PubMed ID: 2432159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
    Murayama S; Syuto B; Oguma K; Iida H; Kubo S
    Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of heterologous component IIs of botulinum C2 toxin.
    Ohishi I; Hama Y
    Microbiol Immunol; 1992; 36(3):221-9. PubMed ID: 1376392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescent-antibody reagents for the identification of Clostridium botulinum.
    Glasby C; Hatheway CL
    J Clin Microbiol; 1983 Dec; 18(6):1378-83. PubMed ID: 6361053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of Clostridium botulinum type E from soil of Gwalior, India.
    Dhaked RK; Sharma SK; Parida MM; Singh L
    J Nat Toxins; 2002 Feb; 11(1):49-56. PubMed ID: 11829060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical toxin variant of Clostridium botulinum type B associated with infant botulism.
    Hatheway CL; McCroskey LM; Lombard GL; Dowell VR
    J Clin Microbiol; 1981 Dec; 14(6):607-11. PubMed ID: 7037830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.
    Sonnabend WF; Sonnabend UP; Krech T
    Appl Environ Microbiol; 1987 Aug; 53(8):1880-4. PubMed ID: 3116935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution.
    Syuto B; Kubo S
    J Biol Chem; 1981 Apr; 256(8):3712-7. PubMed ID: 6783645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity.
    Ohishi I; Sakaguchi G
    Infect Immun; 1982 Jan; 35(1):1-4. PubMed ID: 7033132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding and cytotoxic effects of Clostridium botulinum type A, C1 and E toxins in primary neuron cultures from foetal mouse brains.
    Kurokawa Y; Oguma K; Yokosawa N; Syuto B; Fukatsu R; Yamashita I
    J Gen Microbiol; 1987 Sep; 133(9):2647-57. PubMed ID: 3329217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunochemical characterization of cell wall protein antigen purified from the cell wall autolysate of Clostridium botulinum type A.
    Takumi K; Kawata T
    Jpn J Microbiol; 1975 Feb; 19(1):1-6. PubMed ID: 51110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
    Shone C; Wilton-Smith P; Appleton N; Hambleton P; Modi N; Gatley S; Melling J
    Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.
    Terajima J; Syuto B; Ochanda JO; Kubo S
    Infect Immun; 1985 May; 48(2):312-7. PubMed ID: 3988338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.